KO - The Coca-Cola Company
51.66 -0.02 (-0.04%)
After hours: 6:12PM EDT
| Previous Close | 51.12 |
| Open | 51.50 |
| Bid | 51.69 x 4000 |
| Ask | 51.78 x 1100 |
| Day's Range | 51.35 - 51.78 |
| 52 Week Range | 42.96 - 52.19 |
| Volume | 9,912,026 |
| Avg. Volume | 11,934,668 |
| Market Cap | 220.388B |
| Beta (3Y Monthly) | 0.28 |
| PE Ratio (TTM) | 32.84 |
| EPS (TTM) | 1.57 |
| Earnings Date | Jul 23, 2019 |
| Forward Dividend & Yield | 1.60 (3.13%) |
| Ex-Dividend Date | 2019-06-13 |
| 1y Target Est | 52.00 |
- Yahoo Finance•3 hours ago
U.S. Soccer Foundation President and CEO: Women's pay issue 'will go on'
The U.S. Women's National Team fights back against gender-pay discrimination, while fighting for back-to-back World Cup titles in France.
- InvestorPlace•8 hours ago
The Blue Chip of Pot: Can CGC Stock Rally 20% on Acreage Deal and Earnings?
Shares of Canopy Growth (NYSE:CGC) are climbing on optimism that its deal for Acreage Holdings (OTCMKTS:ACRGF) will go through. On Wednesday the deal received CGC stock shareholder approval, just leaving regulators on the table for a potential headwind. We also have this afternoon's earnings to get through.Source: Shutterstock By and large, the deal is expected to go through, particularly given some of the board members involved. Acreage board members include former Republican Congressman and Speaker of the United States House John Boehner and Brian Mulroney, the former Conservative Prime Minister of Canada -- among others.Many expect the $3.4 billion cash and stock deal to go through, leaving Canopy with a big asset for future growth here in the U.S.InvestorPlace - Stock Market News, Stock Advice & Trading TipsWhen investors think of blue-chip stocks, Canopy won't be the first that comes to mind. Procter & Gamble (NYSE:PG), Coca-Cola (NYSE:KO) and others are what investors think of, but that doesn't matter. CGC stock has quickly proven that it's the best of the best when it comes to cannabis investments. Canopy Growth Is a Blue Chip StockAfter Constellation Brands (NYSE:STZ) invested some $4 billion into the company, it loaded CGC's bank account. But the deal gave Canopy a lot more than a good reputation. Suddenly, it had a powerful balance sheet as a major asset. It could afford to enter new markets, gobble up high-growth companies and essentially lead the land-grab charge as cannabis gains momentum. Further yet, it had a high-quality and reputable company staking big-time money on Canopy's leadership. That gives the company some clout. * Check Out These 5 Fast-Growing Stocks to Buy Today If Constellation trusts Canopy with $4+ billion, why shouldn't I? That's what a lot of investors and other companies found themselves asking.CGC stock has built a foundation in Canada and is working on global expansion in Europe and Australia, while its Acreage Holdings deal positions itself for the coming landslide in the U.S. While its valuation doesn't quite reflect its current fundamentals, investors are betting on its long-term potential.In essence, they are betting that CGC will become the PepsiCo (NYSE:PEP) or Coca-Cola of its industry. That's not to say New Age Beverages (NASDAQ:NBEV), Aurora Cannabis (NYSE:ACB) or Cronos Group (NYSE:CRON) won't be winners either. Just that CGC is becoming the 800-lb gorilla of the group.From the most recent earnings release:"Our successful first full quarter with recreational sales in Canada reinforces our long held strategy of making meaningful investments early in order to secure market share," said Bruce Linton, Chairman & Co-CEO, Canopy Growth. "With a strong cash position, we added strategic assets and IP through acquisitions to accelerate the sophistication of our inputs with ebbu, and our consumer-facing outputs with Storz and Bickel." Trading CGC Stock Click to EnlargeCGC stock is now pushing through its 20-day and 200-day moving averages. If it can continue to push higher, its 50-day moving average near $44.50 is in sight. This stock has been volatile, but continues to very slowly push out new highs.Unfortunately, those new highs are often met with a wave of selling. For instance, after hitting $52 in February, Canopy Growth stock quickly retreated, falling to sub-$42 -- a 19% drop -- in just six trading sessions. It traded sideways for a while after that, before eventually pushing up through $52. A month later, shares were at $38.38. The peak to trough decline was more than 27% that time.So what can we expect on this go around? Much of it will depend on earnings, set for after the close on June 20th.I'm looking to see if CGC stock price can again climb back to $52. If it can, it will represent a 20% rally from current levels. As we said above, Canopy stock is a blue chip name among the cannabis industry. If this group regains momentum, so too should CGC. Earnings may be the spark for that momentum, but we won't know until Friday morning. * 6 Stocks Ready to Bounce on a Trade Deal If the earnings results inspire investors to gobble up CGC stock, upside targets of $48 and $52 are within reach. If the reaction is negative or if the 50-day acts as resistance, I'm looking for support near $40. Below opens the door to some serious declines, but let's not get ahead of our skis. Let's see the report before going any further.Bret Kenwell is the manager and author of Future Blue Chips and is on Twitter @BretKenwell. As of this writing, Bret Kenwell did not hold a position in any of the aforementioned securities. More From InvestorPlace * 4 Top American Penny Pot Stocks (Buy Before June 21) * 7 Blue-Chip Stocks to Buy for a Noisy Market * 5 Strong Buy Biotech Stocks for the Second Half * 6 Stocks Ready to Bounce on a Trade Deal Compare Brokers The post The Blue Chip of Pot: Can CGC Stock Rally 20% on Acreage Deal and Earnings? appeared first on InvestorPlace.
- Business Wire•10 hours ago
The Coca-Cola Company Announces Timing of Second Quarter 2019 Earnings Release
The Coca-Cola Company today announced it will release second quarter 2019 financial results on July 23 before the New York Stock Exchange opens. The release will be followed by an investor conference call at 8:30 a.m.
- Insider Monkey•2 days ago
Locust Wood Capital Advisers’ Return, AUM, and Holdings
Back in 2002 Stephen J. Errico, a Wall Street investor, who now has more than 30 years of professional investing experience, launched his own NYC-based hedge fund, Locust Wood Capital Advisers. Aside from being the fund's founder he is also its CIO and Controling Principal. Previously, Mr. Errico worked at Morgan Stanley as a portfolio […]
- Financial Times•2 days ago
Like a Virgin? Challenger bank CYBG looks to Branson brand
Yorkshire’s small business owners no longer think “where there’s muck, there’s brass”. Or so market research by Clydesdale and Yorkshire Banking Group would seem to suggest. Straight-talking Yorkshire pragmatism is out.
- Yahoo Finance•3 days ago
There are signs of stock market 'micro-bubbles'
The market right now is not without its bubbles, suggests Charles Schwab chief investment strategist Liz Ann Sonders.
- Motley Fool•4 days ago
5 Companies Looking to Cash In on Netflix's "Stranger Things"
Merchandising is a small but growing area of Netflix's business.
- Zacks•4 days ago
Coca-Cola (KO) Stock Sinks As Market Gains: What You Should Know
Coca-Cola (KO) closed the most recent trading day at $50.87, moving -0.86% from the previous trading session.
- Kiplinger•4 days ago
The Berkshire Hathaway Portfolio: All 48 Buffett Stocks
When folks think of the Berkshire Hathaway (BRK.B) portfolio and its collection of holdings, most of which were selected by Chairman and CEO Warren Buffett, the companies that most readily come to mind are probably American Express (AXP), Coca-Cola (KO) and, more recently, Apple (AAPL).But a deep dive into Berkshire Hathaway's equity holdings reveals a more complicated picture.Berkshire Hathaway held positions in 48 separate stocks as of March 31, according to regulatory filings with the Securities and Exchange Commission. But the portfolio of "Buffett stocks" isn't as diversified as the number might suggest. In some cases, BRK.B holds more than one share class in the same company. Some holdings are so small as to be immaterial leftovers from earlier bets the Oracle of Omaha has yet to completely exit.And perhaps most importantly, Berkshire Hathaway's equity portfolio is actually pretty concentrated. The top six holdings account for almost 70% of the portfolio's total value. The top 10 positions comprise nearly 80%. Banks and airlines, to cite a couple of sectors, carry quite a load in this portfolio. Then there's the fact that several Buffett stocks actually were picked by portfolio managers Todd Combs and Ted Weschler.Here, we examine each and every holding to give investors a better understanding of the entire Berkshire Hathaway portfolio. SEE ALSO: The 19 Best Stocks to Buy for the Rest of 2019
- Barrons.com•4 days ago
Keurig Dr Pepper Upgrade Sends Stock Soaring to Record
BMO Capital Markets lifted its price target on the beverage maker’s stock citing an upbeat growth outlook for the coming years.
- InvestorPlace•4 days ago
NBEV Stock Is More Than Just CBD — But It’s Still Not Enough
In a frothy market you can get a mighty high multiple if you're in the right niche. Like marijuana. That's the story of New Age Beverages (NASDAQ:NBEV). NBEV stock tripled last September after announcing a drink containing CBD. Its drinks even have a picture of the late Bob Marley on them.But pot isn't NBEV's real business. Canned beverages are its business. Things like coffee, tea and kombucha. Sodas with strange combinations like watermelon and coconut, the kind of stuff you'll try at a soda ranch on Route 66.InvestorPlace - Stock Market News, Stock Advice & Trading TipsSince that September explosion, where it briefly traded at almost $9, NBEV stock has lost its fizz, settling into a trading range of between $4-6 per share. But its market cap, $350 million, remains impressive for a drinks company with March quarter sales of $58 million, and no profit.But still. Pot! What NBEV Is Up ToNew Age Beverages has used its moment in the pot limelight to bulk up the product line. The highlight was this month's purchase of Brands Within Reach, for $6.4 million, only $500,000 of it cash. * 7 Top-Rated Biotech Stocks to Invest In Today Brands Within Reach has brand licensing and distribution rights for some mainstream beverages, like cold Nestea and Illy coffee. The idea is that this gets New Age in the door at mainstream retailers like Walmart (NYSE:WMT) and Costco Wholesale (NASDAQ:COST), which then might look at its more esoteric brands.This came just six months after buying Morinda Holdings, another small company but with distribution in 60 countries. The idea there was to expand the market for its CBD products.The Morinda combination is already in the numbers due to be reported August 8, where sales of $70.8 million are expected. Following on the first quarter take of $58 million, that's good growth and, if the pattern persists through the year, it could lead to sales equaling the stock's current market cap by this time next year.That's important, because New Beverage CEO Brent Willis knows he's in the drinks business, not the pot business. He promised to focus on execution after buying Morinda, but the chance to buy into serious beverages with just stock was too good to pass up. What Next for NBEV Stock?Some analysts got very bullish on New Age after the Morinda buy, predicting imminent profits and a steady rise to $9 per share, which would be double its current level.InvestorPlace's Josh Enomoto disagrees. He sees the Brands Within Reach acquisition as a turn away from CBD, the source of its frothy valuation. He also sees the current brands as nothing special.Personally, I like the Brands Within Reach deal. NBEV now has both brands that can get it into the door of big retailers and global distribution for its CBD products. But drinks remain a risky business, a land of giants in which NBEV is a mouse. If Coca-Cola (NYSE:KO), Pepsico (NYSE:PEP) or even Keurig Dr Pepper (NYSE:KDP) decided there was something to this CBD thing, they could blow NBEV out of the water quickly. The Bottom Line on NBEV StockI think the owners of Brands Within Reach know all this, so there's an overhang of almost $6 million in stock, itching to be sold right now.Much of the rest of the common stock is held by speculators looking for a quick payout. Institutions hold just over 13% of the common, against almost 26% held by insiders. I think they will bail, too, at the first sign of bad news. * 7 Top-Rated Biotech Stocks to Invest In Today In other words, NBEV stock has a sell-by date, and execution alone won't stave it off.Dana Blankenhorn is a financial and technology journalist. He is the author of the mystery thriller, The Reluctant Detective Finds Her Family, available at the Amazon Kindle store. Write him at danablankenhorn@gmail.com or follow him on Twitter at @danablankenhorn. As of this writing he owned no shares in companies mentioned in this article. Compare Brokers The post NBEV Stock Is More Than Just CBD -- But It's Still Not Enough appeared first on InvestorPlace.
- Investor's Business Daily•4 days ago
3 Surprising Ways To Profit From Lower Interest Rates
Opportunity lies with low and falling interest rates, says Mark DiOrio of Brookstone Capital Management. You just need to position yourself right.
- Investing.com•4 days ago
Stocks - U.S. Futures Inch up as Investors Await Fed Meeting
In commodities, crude oil fell 0.7% to $52.17 a barrel after reaching an earlier high of $52.91. CFTC data showed the number of long speculative positions on oil had fallen to its lowest level since March last week after a seventh straight weekly drop. Gold futures slipped 0.6% to $1,337.15 a troy ounce while the U.S. dollar index, which measures the greenback against a basket of six major currencies, was flat at 97.032.
- Investopedia•5 days ago
Coca-Cola vs. Pepsi's Business Models: What's the Difference?
Understand more about the Coca-Cola company and the PepsiCo company. Learn about the key similarities and differences that make both companies successful.
- American City Business Journals•6 days ago
Retired Coca-Cola Chairman Muhtar Kent buys Buckhead condo (Photos)
The former head of one of Atlanta's most recognized global companies has purchased a three bedroom, high-rise condominium in Buckhead. Retired Coca-Cola Chairman and CEO Muhtar Kent, as trustee of the Muhtar Kent Revocable Trust as amended and restated dated 4/23/18, bought Residence 2010 at the St. Regis Atlanta, 88 W. Paces Ferry Road, Atlanta, for $4.35 million from SR Atlanta Residences LLC, a Georgia limited liability company, on May 15, according to Fulton County property records.
- American City Business Journals•8 days ago
Nike partners with Netflix and ‘Stranger Things’ to bring back nostalgic 80s shoes and show inspired clothing
Nike joins the list of major brands partnering with Netflix to release “Stranger Things” themed products ahead of the Season 3 debut.
- GuruFocus.com•8 days ago
Warren Buffett Explains the Difference Between Good and Bad Businesses
A great business does not throw up difficult decisions
- InvestorPlace•8 days ago
Cronos Group Stock Is Just Getting Started
The long-term prospects for Cronos Group (NASDAQ:CRON) stock look good. That is, if you ask CRON stock fans. There is almost no convincing them otherwise. Critics of Cronos Group stock and the whole industry can offer smartest arguments to prove that the cannabis stocks are headed for disaster, but it will all fall on deaf ears.Source: Shutterstock The bullish thesis for the industry is so vague and the scope is so widespread that it's almost impossible to kill it this year. It is a multi-headed beast where if the bears chop off one head, many others will stare them down with sharp teeth.Don't take my word for it, just consider the scoreboard. CRON is up 64% year-to-date -- leading the pot stock pack. The ETFMG Alternative Harvest ETF (NYSEARCA:MJ) is up only 30%. And I say this while I chuckle because that's still double the S&P 500 performance for the same period. So CRON is up four times more than the S&P.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 6 Growth Stocks That Could Be the Next Big Thing This is similar to how it was for Amazon (NASDAQ:AMZN) and Netflix (NASDAQ:NFLX) in their infancy stages. This is also very similar to the current situation with Beyond Meat (NASDAQ:BYND) and even Uber (NYSE:UBER). The bullish thesis for these types of pioneer stocks is too vague to try too short this early.This is not the same as saying that I drank the Kool-Aid think pot stocks will be as successful as AMZN long term. I am merely saying that it's too early to short them. Trading CRON StockSo do I go all in on CRON? No, but still this all depends on individual time frames and risk appetites. One thing is for sure, pot stocks make for great short-term trading vehicles so CRON has opportunities on both the upside and downside. Those who believe in it long term, this is as good as any to buy at least half their position. It is futile to wait for a perfect sign to enter.Mid term, I favor the upside potential through the rest of the year for CRON stock because it established a solid band of support. Since January of 2018, $14 per share played an important role. It served as a major pivot point, so it is an area where bulls and bears are consistently eager to fight it out hard.This creates congestion so it becomes a sticky zone. And since CRON stock price is above it, the bulls can use it as solid footing. Meaning onus is on the bears to break that. Otherwise, every dip towards it is a buying opportunity. Sustaining the selling then becomes almost impossible.So this leaves us with evaluating the upside potential at hand. Earlier I mentioned that there are shorter- term time frames to trade. Above $18 per share, CRON will invite momentum buyers to launch a $4 rally from there. There will be resistance near $20. This sounds like a wild statement, but it is doable for such a momentum stock.I also noted that the $14 per share zone is a long term pivot, but so is $16. Specifically for this year, it served as a major point of contention. So I expect $16 to be the immediate support. For those who like to sell credit put spreads to generate income, that would be a good short-term level to consider.Conversely, there is risk below especially due to trade uncertainties. So we are vulnerable to geopolitical headlines to cause sporadic selloffs. If Cronos stock fills the gap below and falls below $13.5 per share, it could trigger a $2 overshoot. While this is not my forecast, it is a scenario that exist below. The Bottom Line on Pot StocksIt is also important to note that I am not a super fan of the whole cannabis sector. But I do recognize that it's a tough short.This is a brand new industry to Wall Street, and marijuana still illegal at the federal level in the U.S. So it has everything going against it. Yet pot stocks still have so much support from everyone from retail investors to mega corporations. Constellation Brands (NYSE:STZ) and Altria (NYSE:MO) were the first two to dip their toes in the water by throwing billions at Canopy Growth (NYSE:CGC) and CRON so we know that they are the best leading cannabis companies.This is just the beginning.Dozens more companies are waiting and trying to figure out how they can also grab a piece of this pie. We all know about the popularity of recreational pot. But there are the slew of other applications that are extremely interesting. Mainly medicinal, edibles, and portables. There is a strong consensus that people will be drinking pot-infused drinks instead of soda, beer or wine. * 7 High-Quality Cheap Stocks to Buy With $10 I am not here to judge whether this is a realistic goal; it's definitely not in the very near term, but it's not out of the realm of possibilities. So the theoretical addressable market is literally incalculable. So what are the bears shorting? Without any negative headlines Cronos stock is going higher.Nicolas Chahine is the managing director of SellSpreads.com. As of this writing, he did not hold a position in any of the aforementioned securities. Join his live chat room free here. More From InvestorPlace * 4 Top American Penny Pot Stocks (Buy Before June 21) * 7 High-Quality Cheap Stocks to Buy With $10 * 7 U.S. Stocks to Buy With Limited Trade War Exposure * 6 Growth Stocks That Could Be the Next Big Thing Compare Brokers The post Cronos Group Stock Is Just Getting Started appeared first on InvestorPlace.
- Markit•8 days ago
See what the IHS Markit Score report has to say about Coca-Cola Co.
Coca-Cola Co NYSE:KOView full report here! Summary * Perception of the company's creditworthiness is negative * ETFs holding this stock are seeing positive inflows * Bearish sentiment is low Bearish sentimentShort interest | PositiveShort interest is extremely low for KO with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting KO. Money flowETF/Index ownership | PositiveETF activity is positive. Over the last month, ETFs holding KO are favorable, with net inflows of $12.10 billion. Additionally, the rate of inflows is increasing. Economic sentimentPMI by IHS Markit | NeutralAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Consumer Goods sector is rising. The rate of growth is weak relative to the trend shown over the past year, however. Credit worthinessCredit default swap | NegativeThe current level displays a negative indicator. KO credit default swap spreads are near their highest levels for the past 1 year, which indicates the market's more negative perception of the company's credit worthiness.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
- Zacks•9 days ago
4 Fitness Stocks to Buy This Summer
Growing consumer preference for a healthy lifestyle could boost America's fitness industry.
- Investing.com•9 days ago
Stocks - Wall Street Flat as Low CPI Neutralizes Trade Tension
The Dow gained 24 points or 0.1% by 9:40 AM ET (13:40 GMT), while the S&P; 500 rose 0.8 points or 0.03% and tech-heavy Nasdaq composite lost 10 points or 0.1%.
- Zacks•10 days ago
Coca-Cola (KO) Dips More Than Broader Markets: What You Should Know
Coca-Cola (KO) closed at $51.33 in the latest trading session, marking a -0.1% move from the prior day.
- American City Business Journals•10 days ago
BB&T Atlanta Open moves to larger site
The ninth-annual BB&T; Atlanta Open, scheduled for July 20-28, is in its first year of a new 5-year contract with Atlantic Station.
- Yahoo Finance Video•5 hours ago
U.S. Soccer Foundation scores big with Powerade partnership
U.S. Soccer Foundation President and CEO Ed Foster-Simeon discusses their new partnership with Powerade, as well as the success of the United States Women's National Team as they look to win the FIFA Women's World Cup this year in France. He joins Yahoo Finance's Zack Guzman and Kristin Myers, along with Carleton English, NY Post Hedge Fund Reporter.
